1. Home
  2. CHEK vs SHPH Comparison

CHEK vs SHPH Comparison

Compare CHEK & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • SHPH
  • Stock Information
  • Founded
  • CHEK 2004
  • SHPH 2012
  • Country
  • CHEK Israel
  • SHPH United States
  • Employees
  • CHEK N/A
  • SHPH N/A
  • Industry
  • CHEK Medical Electronics
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEK Health Care
  • SHPH Health Care
  • Exchange
  • CHEK Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • CHEK 3.9M
  • SHPH 3.2M
  • IPO Year
  • CHEK 2015
  • SHPH 2022
  • Fundamental
  • Price
  • CHEK $1.24
  • SHPH $2.52
  • Analyst Decision
  • CHEK
  • SHPH
  • Analyst Count
  • CHEK 0
  • SHPH 0
  • Target Price
  • CHEK N/A
  • SHPH N/A
  • AVG Volume (30 Days)
  • CHEK 98.8K
  • SHPH 463.6K
  • Earning Date
  • CHEK 11-28-2025
  • SHPH 11-13-2025
  • Dividend Yield
  • CHEK N/A
  • SHPH N/A
  • EPS Growth
  • CHEK N/A
  • SHPH N/A
  • EPS
  • CHEK N/A
  • SHPH N/A
  • Revenue
  • CHEK N/A
  • SHPH N/A
  • Revenue This Year
  • CHEK N/A
  • SHPH N/A
  • Revenue Next Year
  • CHEK N/A
  • SHPH N/A
  • P/E Ratio
  • CHEK N/A
  • SHPH N/A
  • Revenue Growth
  • CHEK N/A
  • SHPH N/A
  • 52 Week Low
  • CHEK $0.56
  • SHPH $2.36
  • 52 Week High
  • CHEK $3.13
  • SHPH $33.85
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 34.47
  • SHPH 29.91
  • Support Level
  • CHEK $1.29
  • SHPH $2.91
  • Resistance Level
  • CHEK $1.35
  • SHPH $3.56
  • Average True Range (ATR)
  • CHEK 0.10
  • SHPH 0.26
  • MACD
  • CHEK -0.05
  • SHPH -0.07
  • Stochastic Oscillator
  • CHEK 1.75
  • SHPH 10.55

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: